COMMUNIQUÉ DE PRESSE publié le 16/03/2026 à 21:30, il y a 7 mois 19 jours Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity Zomedica reports record $10 million quarterly revenue, 20th consecutive year-over-year growth. Financial highlights and strategic outlook unveiled Growth Strategy Financial Results Revenue Growth Zomedica Animal Health
BRÈVE publiée le 10/03/2026 à 11:35, il y a 7 mois 25 jours Zomedica présentera ses résultats financiers pour 2025 et ses perspectives sur le marché équin. Webinaire Zomedica Résultats Financiers 2025 Marché Équin Solutions Vétérinaires
BRÈVE publiée le 10/03/2026 à 11:35, il y a 7 mois 25 jours Zomedica to Showcase 2025 Financials and Equine Market Insights Webinar Zomedica Equine Market 2025 Financial Results Veterinary Solutions
COMMUNIQUÉ DE PRESSE publié le 10/03/2026 à 11:30, il y a 7 mois 25 jours Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar Zomedica Corp. announces upcoming investor webinar to discuss full-year 2025 financial results, equine veterinary market insights, and product portfolio. Event to feature live Q&A session Zomedica Corp. Product Portfolio Investor Webinar 2025 Financial Results Equine Veterinary Market
BRÈVE publiée le 25/02/2026 à 12:35, il y a 8 mois 7 jours Zomedica and Moichor Collaborate on TRUVIEW Digital Microscopy Distribution AI Integration Zomedica Veterinary Diagnostics TRUVIEW Moichor
BRÈVE publiée le 25/02/2026 à 12:35, il y a 8 mois 7 jours Zomedica et Moichor collaborent à la distribution du microscope numérique TRUVIEW Zomedica Intégration De L'IA Diagnostic Vétérinaire TRUVIEW Moichor
COMMUNIQUÉ DE PRESSE publié le 25/02/2026 à 12:30, il y a 8 mois 7 jours Zomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology Zomedica Corp. partners with Moichor to expand access to TRUVIEW digital microscopy systems in veterinary practices, enhancing diagnostic capabilities and supporting recurring revenue growth Zomedica Corp. Veterinary TRUVIEW Moichor Digital Microscopy
BRÈVE publiée le 05/02/2026 à 12:35, il y a 8 mois 27 jours Zomedica organise un webinaire en février sur la R&D et l'innovation Innovation Webinaire Zomedica Santé Animale Stratégie De R&D
BRÈVE publiée le 05/02/2026 à 12:35, il y a 8 mois 27 jours Zomedica Schedules February Webinar on R&D and Innovation Innovation Webinar Zomedica Animal Health R&D Strategy
COMMUNIQUÉ DE PRESSE publié le 05/02/2026 à 12:30, il y a 8 mois 27 jours Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline Zomedica's R&D strategy for scalable growth and long-term shareholder value highlighted in Fourth Friday at Four investor webinar on February 27, 2026, 4:00 p.m. ET Zomedica Investor Webinar R&D Strategy Long-term Value Scalable Growth
Publié le 04/11/2026 à 18:00, il y a 10 heures The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 10 heures L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 10 heures 17 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 4 heures 51 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 5 heures 1 minute Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 5 heures 46 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 56 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 03:55, il y a 5 minutes AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Publié le 05/11/2026 à 03:10, il y a 50 minutes SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Publié le 05/11/2026 à 00:02, il y a 3 heures 58 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 8 heures 19 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 8 heures 35 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting